AnyGenes® provides services of integrated approaches for translational medicine, based on a broad range of innovative technologies for drug development including drug screening and testing in in vitro cell culture, efficacy and safety, mechanism of action, search & validation of biomarker signature, data analysis and patient stratification. Our goal is to help in the efficient development of new targeted drugs by developing innovative tools, which allow selecting patients most likely to respond to a developed targeted therapy.
AnyGenes® has its own i) laboratories with well-equipped platform and validated technologies for gene expression, protein analysis, mutation detection, copy number and variants analysis, methylation analysis… ii) biocomputer platform for efficient data analysis:
AnyGenes® scientific team has great ability to adapt our offer to your project needs, we are willing to assist you: [email protected]
AnyGenes® provides full services for high-throughput data analysis concerning many application fields:
- In Vitro Drug analysis
- Histoculture Drug Response Assays (HDRA) systems
- Biomarkers identification and validation studies based on our own qPCR signaling pathways (SignArrays®)
- DNA Methylation analysis by pyrosequencing and epigenetic regulation signaling pathways
- Next-Generation Sequencing (NGS) data analysis
- and so much more !